Cancer Biology & Therapy

Papers
(The H4-Index of Cancer Biology & Therapy is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Correction96
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers60
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis55
Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition43
Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma43
Evaluating massage therapy for radiation-induced fibrosis in rats: preliminary findings and palpation results42
Correction41
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway37
Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article36
A comparison of cell death pathways in three different kinds of human lung cancer cell lines following hematoporphyrin derivative-mediated photodynamic therapy32
Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment‎30
CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells30
Advancements in exosome-based cancer diagnosis: from chipsets to nano vaccine30
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA1828
Immunotherapy resistance in solid tumors: mechanisms and potential solutions27
Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells27
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy26
Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature25
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer25
GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT325
Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells24
Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer23
LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors in vitro and tumor growth and metastasis in vivo through the PI3K/Akt s23
SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression23
0.77554202079773